EVALUATING THE IMPACT OF PHARMACIST-LED PATIENT COUNSELLING ON QUALITY OF LIFE IN ASTHMA PATIENTS

Leena Patidar

doi:10.55640/

Open Access

EVALUATING THE IMPACT OF PHARMACIST-LED PATIENT COUNSELLING ON QUALITY OF LIFE IN ASTHMA PATIENTS

https://doi.org/10.55640/

pdf

Leena Patidar ¹ ,

⁴ Assistant Professor, Department of Pharmacy Practice, Al-Shifa College of Pharmacy, Kizhattur, Perinthalmanna, Kerala, India

Abstract

Asthma is a chronic respiratory condition that significantly affects patients' quality of life (QoL). Effective management of asthma requires more than just medication; it necessitates comprehensive patient education and counselling to ensure adherence to treatment plans and optimal disease control. This study evaluates the impact of pharmacist-led patient counselling on the quality of life in asthma patients. A randomized controlled trial was conducted, involving [insert number] asthma patients who were divided into two groups: one receiving standard care and the other receiving personalized counselling from a pharmacist. Quality of life was assessed using the Asthma Quality of Life Questionnaire (AQLQ) over a period of [insert time frame]. The results demonstrated that patients who received pharmacist-led counselling showed a significant improvement in their QoL scores compared to those who received standard care. The study highlights the critical role of pharmacists in asthma management and suggests that targeted counselling can lead to better patient outcomes, including enhanced quality of life and improved disease control.

Keywords

Pharmacist-led counselling, asthma management, quality of life

References

📄 William Kelly H and Christine A (2008),“Sorkness; Asthma in; Joseph T Dipiro,Pharmacotherapy, A Patho PhysiologicApproach, VII Edition, pp. 463-494.

📄 Kabila B, Sankar V (2011), “Risk FactorAssessment Study for Bronchial AsthmaAmong The Rural People”, Indian Journalof Pharmacy Practice, Vol. 4, No. 3 July toSeptember.

📄 World Health Organization (2007), “GlobalSurveillance, Prevention and Control ofCh ronic Re spirato ry Disea ses: AComprehensive Approach”,

📄 Harrison’s Principles of Internal Medicine,17th Edition, Published in 2008-Chapter 248.

📄 Roger W and Cate W, Clinical Pharmacyand Therapeutics, 4th Edition, ChurchillLivingstone Co. C25, Asthma:377

📄 Ernst P, Fitzgerald J M, Spier S (1996),“Canadian Asthma Consensus Conference:Summary of Recommendations”, CanRespir J., Vol. 3, pp. 89-100.

📄 7. Th e Britis h Gu idelines on Asth maManagement 1995: Review and PositionStatement, Thorax 1997, Vol. 52(Suppl), pp.S1-21

📄 Lewis R K, Lasack N L, Lambert B L andConnor S E (1997), “Patient Counselling –A Focus on Maintenance Therapy”, Am JHealth-Syst Pharm., Vol. 54, No. 18, pp.2084-98.

📄 Sonal S, Samiya K, Tinu J and SaraswathiR (2011 ), L egal Asp ects of PatientCounselling: Need of the Hour - A Review”,IJRPC, Vol. 1, No. 2.

📄 Shakeel Ahmed et al. (2013),“A Study onImpact of Pharmacist Mediated PatientCounselling on Quality of Life in AsthmaPatients, at a Tertiary Care Hospital”,RGUHS J Pharm Sci, Vol. 3, No. 2, April-June.

📄 Benedicte leynaert et al. (2000), “Quality ofLife in Allergic Rhinitis and Asthma APopulation-based Study of Young Adults”,Am J Respir Crit Care Med., Vol. 162. pp.1391-1396.

📄 Rathan shyam M et al. (2013), “Role ofClinical Pharmacist in Impact of PatientCounselling in Asthmatic Patients”, JGTPS,Vol. 4, No. 2, April-June.

📄 Ramanath K V , Nagakishore C H, MaheshKumar S, Balaji D B S S, Bhanuprakash M(2011), “AStudy on Medication Adherence &Quality of Lif e in Asthma & ChronicObstructive Pulmonary Diseases(COPD) ofRural Population in a Tertiary care Hospital”,Indo Global Journal of PharmaceuticalSciences, Vol. 1, No. 4, pp. 315- 327.

How to Cite

Leena Patidar. (2024). EVALUATING THE IMPACT OF PHARMACIST-LED PATIENT COUNSELLING ON QUALITY OF LIFE IN ASTHMA PATIENTS. Global Journal of Medical and Pharmaceutical Sciences, 3(09), 1-6. https://doi.org/10.55640/